JPH07308564A - シヤフォームマトリックスの製造方法及び装置 - Google Patents
シヤフォームマトリックスの製造方法及び装置Info
- Publication number
- JPH07308564A JPH07308564A JP5264993A JP26499393A JPH07308564A JP H07308564 A JPH07308564 A JP H07308564A JP 5264993 A JP5264993 A JP 5264993A JP 26499393 A JP26499393 A JP 26499393A JP H07308564 A JPH07308564 A JP H07308564A
- Authority
- JP
- Japan
- Prior art keywords
- raw material
- temperature
- feedstock
- nozzle
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011159 matrix material Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 47
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 239000012530 fluid Substances 0.000 claims abstract description 29
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 22
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 22
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 22
- 238000010008 shearing Methods 0.000 claims abstract description 19
- 229930006000 Sucrose Natural products 0.000 claims abstract description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 13
- 230000007246 mechanism Effects 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims description 81
- 239000000463 material Substances 0.000 claims description 51
- 238000010438 heat treatment Methods 0.000 claims description 30
- 239000003921 oil Substances 0.000 claims description 20
- 235000019198 oils Nutrition 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 238000002347 injection Methods 0.000 claims description 19
- 239000007924 injection Substances 0.000 claims description 19
- 238000012545 processing Methods 0.000 claims description 15
- 238000002425 crystallisation Methods 0.000 claims description 13
- 230000008025 crystallization Effects 0.000 claims description 12
- 239000005720 sucrose Substances 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 230000000996 additive effect Effects 0.000 claims description 10
- 150000001720 carbohydrates Chemical class 0.000 claims description 10
- 239000006260 foam Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000012876 carrier material Substances 0.000 claims description 7
- 239000003607 modifier Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 238000007664 blowing Methods 0.000 claims description 3
- 239000000828 canola oil Substances 0.000 claims description 3
- 235000019519 canola oil Nutrition 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 3
- 239000002285 corn oil Substances 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims description 3
- 238000007711 solidification Methods 0.000 claims description 3
- 230000008023 solidification Effects 0.000 claims description 3
- 241000238424 Crustacea Species 0.000 claims description 2
- 235000019486 Sunflower oil Nutrition 0.000 claims description 2
- 239000004621 biodegradable polymer Substances 0.000 claims description 2
- 229920002988 biodegradable polymer Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 239000002600 sunflower oil Substances 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 229920001169 thermoplastic Polymers 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 235000019737 Animal fat Nutrition 0.000 claims 1
- 229940013317 fish oils Drugs 0.000 claims 1
- 238000002407 reforming Methods 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 52
- 239000000047 product Substances 0.000 description 34
- 235000000346 sugar Nutrition 0.000 description 27
- 239000000243 solution Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 10
- 238000009987 spinning Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 150000008163 sugars Chemical class 0.000 description 7
- 239000006057 Non-nutritive feed additive Substances 0.000 description 6
- 238000013329 compounding Methods 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 229920002245 Dextrose equivalent Polymers 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- -1 pentatol Chemical compound 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229940050561 matrix product Drugs 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000006911 nucleation Effects 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003474 anti-emetic effect Effects 0.000 description 2
- 239000002111 antiemetic agent Substances 0.000 description 2
- 239000003434 antitussive agent Substances 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940125725 tranquilizer Drugs 0.000 description 2
- 239000003204 tranquilizing agent Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- USVZHTBPMMSRHY-UHFFFAOYSA-N 8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9-[2-(2-chlorophenyl)ethyl]purin-6-amine Chemical compound C=1C=2OCOC=2C=C(Br)C=1SC1=NC=2C(N)=NC=NC=2N1CCC1=CC=CC=C1Cl USVZHTBPMMSRHY-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 239000000866 Neuromuscular Agent Substances 0.000 description 1
- 241001585714 Nola Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 239000003263 anabolic agent Substances 0.000 description 1
- 229940124325 anabolic agent Drugs 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000000228 antimanic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940125710 antiobesity agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 229940043671 antithyroid preparations Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011437 continuous method Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000000913 erythropoietic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940125695 gastrointestinal agent Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 239000000864 hyperglycemic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/54—Composite products, e.g. layered, coated, filled
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/02—Apparatus specially adapted for manufacture or treatment of sweetmeats or confectionery; Accessories therefor
- A23G3/10—Candy-pulling machines ; Processes or apparatus for making cotton candy or candy floss
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Mechanical Engineering (AREA)
- Confectionery (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
- Glanulating (AREA)
- Fats And Perfumes (AREA)
- Formation And Processing Of Food Products (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Press-Shaping Or Shaping Using Conveyers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/965,804 US5380473A (en) | 1992-10-23 | 1992-10-23 | Process for making shearform matrix |
| US07/965804 | 1992-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07308564A true JPH07308564A (ja) | 1995-11-28 |
Family
ID=25510508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5264993A Pending JPH07308564A (ja) | 1992-10-23 | 1993-10-22 | シヤフォームマトリックスの製造方法及び装置 |
Country Status (10)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112109231A (zh) * | 2020-08-26 | 2020-12-22 | 常宇 | 一种聚丙烯的生产方法 |
Families Citing this family (121)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6673335B1 (en) * | 1992-07-08 | 2004-01-06 | Nektar Therapeutics | Compositions and methods for the pulmonary delivery of aerosolized medicaments |
| US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| NZ257212A (en) * | 1992-09-29 | 1996-11-26 | Inhale Therapeutic Syst | Parathyroid hormone formulations comprising a biologically active n-terminal fragment of the hormone |
| CA2128820A1 (en) * | 1993-07-27 | 1995-01-28 | Walter G. Gowan, Jr. | Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
| US5518551A (en) * | 1993-09-10 | 1996-05-21 | Fuisz Technologies Ltd. | Spheroidal crystal sugar and method of making |
| US5597416A (en) * | 1993-10-07 | 1997-01-28 | Fuisz Technologies Ltd. | Method of making crystalline sugar and products resulting therefrom |
| US5935600A (en) * | 1993-09-10 | 1999-08-10 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing comestible unit and product therefrom |
| US5895664A (en) * | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
| US5622719A (en) * | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
| US5965162A (en) * | 1993-09-10 | 1999-10-12 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
| PT748213E (pt) * | 1994-03-07 | 2004-08-31 | Nektar Therapeutics | Metodos e composicoes para administracao pulmonar de insulina |
| US20030113273A1 (en) * | 1996-06-17 | 2003-06-19 | Patton John S. | Methods and compositions for pulmonary delivery of insulin |
| JPH10500672A (ja) * | 1994-05-18 | 1998-01-20 | インヘイル セラピューティック システムズ，インコーポレイティド | インターフェロンの乾燥粉末製剤に関する方法及び組成物 |
| US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
| US5582855A (en) | 1994-07-01 | 1996-12-10 | Fuisz Technologies Ltd. | Flash flow formed solloid delivery systems |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| US6586006B2 (en) | 1994-08-04 | 2003-07-01 | Elan Drug Delivery Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| US6083430A (en) * | 1994-10-28 | 2000-07-04 | Fuisz Technologies Ltd. | Method of preparing a dosage unit by direct tableting and product therefrom |
| US5683720A (en) * | 1994-10-28 | 1997-11-04 | Fuisz Technologies Ltd. | Liquiflash particles and method of making same |
| US5587198A (en) | 1995-05-31 | 1996-12-24 | Fuisz Technologies Ltd. | Positive hydration method of preparing confectionery and product therefrom |
| US6964771B1 (en) | 1995-06-07 | 2005-11-15 | Elan Drug Delivery Limited | Method for stably incorporating substances within dry, foamed glass matrices |
| US6391338B1 (en) | 1995-09-07 | 2002-05-21 | Biovail Technologies Ltd. | System for rendering substantially non-dissoluble bio-affecting agents bio-available |
| US5637326A (en) * | 1995-12-04 | 1997-06-10 | Fuisz Technologies Ltd. | Apparatus for making chopped amorphous fibers with an air transport system |
| EP1006806B1 (en) * | 1996-04-11 | 2006-09-13 | Loders Croklaan B.V. | Free flowing fat compositions |
| US6468782B1 (en) * | 1996-12-05 | 2002-10-22 | Quadrant Healthcare (Uk) Limited | Methods of preserving prokaryotic cells and compositions obtained thereby |
| CA2281473C (en) | 1997-02-20 | 2007-01-16 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| JP2002509434A (ja) * | 1997-06-24 | 2002-03-26 | フィス テクノロジーズ リミテッド | 菓子を調製する明確な水和の方法および前記方法からの製品 |
| US20030035778A1 (en) * | 1997-07-14 | 2003-02-20 | Robert Platz | Methods and compositions for the dry powder formulation of interferon |
| US5980941A (en) * | 1997-08-20 | 1999-11-09 | Fuisz Technologies Ltd. | Self-binding shearform compositions |
| US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6612826B1 (en) * | 1997-10-15 | 2003-09-02 | Iap Research, Inc. | System for consolidating powders |
| WO1999048379A1 (en) * | 1998-03-23 | 1999-09-30 | Fuisz Technologies Ltd. | Calcium-based chewy nougat formulation with magnesium |
| IE980395A1 (en) | 1998-05-22 | 1999-12-01 | Fuisz Internat Ltd Fuisz House | Method and appartus for forming and encapsulated product matrix |
| EP1085940A1 (en) * | 1998-05-22 | 2001-03-28 | Biovail International Limited | Method and apparatus for forming an encapsulated product matrix |
| US5976603A (en) * | 1998-08-26 | 1999-11-02 | Fuisz Technologies Ltd. | Fiber and vitamin-fortified drink composition and beverage and method of making |
| WO2000013522A1 (en) * | 1998-09-08 | 2000-03-16 | Fuisz Technologies Ltd. | Chewy nougat confectionery formulation with caffeine |
| US6171607B1 (en) | 1998-09-28 | 2001-01-09 | Fuisz Technologies Ltd. | Process and apparatus for producing shearform matrix material |
| PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
| US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| WO2002003966A2 (en) * | 2000-07-10 | 2002-01-17 | Therics, Inc. | Method and materials for controlling migration of binder liquid in a powder |
| US20020106368A1 (en) * | 2000-07-28 | 2002-08-08 | Adrian Bot | Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same |
| DK1458360T3 (da) | 2001-12-19 | 2011-08-29 | Novartis Ag | Pulmonær afgivelse af aminoglycosider |
| US9079246B2 (en) | 2009-12-08 | 2015-07-14 | Baker Hughes Incorporated | Method of making a nanomatrix powder metal compact |
| US8403037B2 (en) * | 2009-12-08 | 2013-03-26 | Baker Hughes Incorporated | Dissolvable tool and method |
| US9682425B2 (en) | 2009-12-08 | 2017-06-20 | Baker Hughes Incorporated | Coated metallic powder and method of making the same |
| US8297364B2 (en) * | 2009-12-08 | 2012-10-30 | Baker Hughes Incorporated | Telescopic unit with dissolvable barrier |
| US9101978B2 (en) | 2002-12-08 | 2015-08-11 | Baker Hughes Incorporated | Nanomatrix powder metal compact |
| US8327931B2 (en) | 2009-12-08 | 2012-12-11 | Baker Hughes Incorporated | Multi-component disappearing tripping ball and method for making the same |
| US9109429B2 (en) | 2002-12-08 | 2015-08-18 | Baker Hughes Incorporated | Engineered powder compact composite material |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| CN1889931A (zh) * | 2003-12-04 | 2007-01-03 | 辉瑞产品公司 | 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法 |
| WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
| ATE399536T1 (de) * | 2003-12-04 | 2008-07-15 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
| BRPI0417348A (pt) * | 2003-12-04 | 2007-03-13 | Pfizer Prod Inc | processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| BRPI0416534A (pt) * | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | composições multiparticuladas com estabilidade melhorada |
| CN1889933A (zh) * | 2003-12-04 | 2007-01-03 | 辉瑞产品公司 | 由基于液体的工艺制备的阿奇霉素多颗粒剂型 |
| US20050136112A1 (en) * | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
| CA2580250C (en) | 2004-09-21 | 2013-05-14 | Dale M. Edgar | Loxapine analogs and methods of use thereof |
| US20070031342A1 (en) * | 2005-06-22 | 2007-02-08 | Nektar Therapeutics | Sustained release microparticles for pulmonary delivery |
| WO2008002676A2 (en) | 2006-06-29 | 2008-01-03 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
| CN105796568A (zh) | 2007-10-20 | 2016-07-27 | 阿西纳斯公司 | 用于调控激酶级联的药物组合物及其使用方法 |
| US9848634B2 (en) | 2009-06-30 | 2017-12-26 | Philip Morris Products S.A. | Smokeless tobacco product |
| US8573295B2 (en) | 2010-11-16 | 2013-11-05 | Baker Hughes Incorporated | Plug and method of unplugging a seat |
| US9243475B2 (en) | 2009-12-08 | 2016-01-26 | Baker Hughes Incorporated | Extruded powder metal compact |
| US10240419B2 (en) | 2009-12-08 | 2019-03-26 | Baker Hughes, A Ge Company, Llc | Downhole flow inhibition tool and method of unplugging a seat |
| US8425651B2 (en) | 2010-07-30 | 2013-04-23 | Baker Hughes Incorporated | Nanomatrix metal composite |
| US8528633B2 (en) | 2009-12-08 | 2013-09-10 | Baker Hughes Incorporated | Dissolvable tool and method |
| US9227243B2 (en) | 2009-12-08 | 2016-01-05 | Baker Hughes Incorporated | Method of making a powder metal compact |
| US9127515B2 (en) | 2010-10-27 | 2015-09-08 | Baker Hughes Incorporated | Nanomatrix carbon composite |
| US8776884B2 (en) | 2010-08-09 | 2014-07-15 | Baker Hughes Incorporated | Formation treatment system and method |
| US9149959B2 (en) * | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
| US9090955B2 (en) | 2010-10-27 | 2015-07-28 | Baker Hughes Incorporated | Nanomatrix powder metal composite |
| US8692001B2 (en) | 2010-10-27 | 2014-04-08 | Dynamix Pharmaceuticals Ltd. | Sulfonamides for the modulation of PKM2 |
| WO2012088438A1 (en) | 2010-12-22 | 2012-06-28 | Eutropics Pharmaceuticals, Inc. | Compositions and methods useful for treating diseases |
| EP2684167B1 (en) | 2011-03-08 | 2020-09-09 | Eutropics Pharmaceuticals, Inc. | Compositions and methods useful for treating diseases |
| US8631876B2 (en) | 2011-04-28 | 2014-01-21 | Baker Hughes Incorporated | Method of making and using a functionally gradient composite tool |
| US9080098B2 (en) | 2011-04-28 | 2015-07-14 | Baker Hughes Incorporated | Functionally gradient composite article |
| WO2012160447A1 (en) | 2011-05-25 | 2012-11-29 | Dynamix Pharmaceuticals Ltd. | 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases |
| CN103717593B (zh) | 2011-06-07 | 2016-07-06 | 克勒韦谢尔制药公司 | 调节激酶的组合物和方法 |
| US9139928B2 (en) | 2011-06-17 | 2015-09-22 | Baker Hughes Incorporated | Corrodible downhole article and method of removing the article from downhole environment |
| US9707739B2 (en) | 2011-07-22 | 2017-07-18 | Baker Hughes Incorporated | Intermetallic metallic composite, method of manufacture thereof and articles comprising the same |
| US8783365B2 (en) | 2011-07-28 | 2014-07-22 | Baker Hughes Incorporated | Selective hydraulic fracturing tool and method thereof |
| US9833838B2 (en) | 2011-07-29 | 2017-12-05 | Baker Hughes, A Ge Company, Llc | Method of controlling the corrosion rate of alloy particles, alloy particle with controlled corrosion rate, and articles comprising the particle |
| US9643250B2 (en) | 2011-07-29 | 2017-05-09 | Baker Hughes Incorporated | Method of controlling the corrosion rate of alloy particles, alloy particle with controlled corrosion rate, and articles comprising the particle |
| US9057242B2 (en) | 2011-08-05 | 2015-06-16 | Baker Hughes Incorporated | Method of controlling corrosion rate in downhole article, and downhole article having controlled corrosion rate |
| US9033055B2 (en) | 2011-08-17 | 2015-05-19 | Baker Hughes Incorporated | Selectively degradable passage restriction and method |
| US9856547B2 (en) | 2011-08-30 | 2018-01-02 | Bakers Hughes, A Ge Company, Llc | Nanostructured powder metal compact |
| US9090956B2 (en) | 2011-08-30 | 2015-07-28 | Baker Hughes Incorporated | Aluminum alloy powder metal compact |
| US9109269B2 (en) | 2011-08-30 | 2015-08-18 | Baker Hughes Incorporated | Magnesium alloy powder metal compact |
| US9643144B2 (en) | 2011-09-02 | 2017-05-09 | Baker Hughes Incorporated | Method to generate and disperse nanostructures in a composite material |
| US9133695B2 (en) | 2011-09-03 | 2015-09-15 | Baker Hughes Incorporated | Degradable shaped charge and perforating gun system |
| US9187990B2 (en) | 2011-09-03 | 2015-11-17 | Baker Hughes Incorporated | Method of using a degradable shaped charge and perforating gun system |
| US9347119B2 (en) | 2011-09-03 | 2016-05-24 | Baker Hughes Incorporated | Degradable high shock impedance material |
| US9284812B2 (en) | 2011-11-21 | 2016-03-15 | Baker Hughes Incorporated | System for increasing swelling efficiency |
| US9010416B2 (en) | 2012-01-25 | 2015-04-21 | Baker Hughes Incorporated | Tubular anchoring system and a seat for use in the same |
| US9068428B2 (en) | 2012-02-13 | 2015-06-30 | Baker Hughes Incorporated | Selectively corrodible downhole article and method of use |
| US9605508B2 (en) | 2012-05-08 | 2017-03-28 | Baker Hughes Incorporated | Disintegrable and conformable metallic seal, and method of making the same |
| US20150150869A1 (en) | 2012-06-20 | 2015-06-04 | Eutropics Pharmaceuticals, Inc. | Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives |
| HUE037637T2 (hu) | 2012-08-30 | 2018-09-28 | Athenex Inc | N-(3-fluorobenzil)-2-(5-(4-morfolinofenil)piridin-2-IL) acetamid, mint fehérje tirozin kináz modulátorok |
| US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| JP6170234B2 (ja) | 2013-03-15 | 2017-07-26 | アプレシア・ファーマスーティカルズ・カンパニー | レベチラセタムを含む急速に分散する剤形 |
| EP2968354B1 (en) | 2013-03-15 | 2019-11-13 | Aprecia Pharmaceuticals LLC | Rapidly dispersible dosage form of oxcarbazepine |
| MX365914B (es) | 2013-03-15 | 2019-06-20 | Aprecia Pharmaceuticals LLC | Forma de dosificación de topiramato dispersable rápidamente. |
| US9816339B2 (en) | 2013-09-03 | 2017-11-14 | Baker Hughes, A Ge Company, Llc | Plug reception assembly and method of reducing restriction in a borehole |
| US10689740B2 (en) | 2014-04-18 | 2020-06-23 | Terves, LLCq | Galvanically-active in situ formed particles for controlled rate dissolving tools |
| US11167343B2 (en) | 2014-02-21 | 2021-11-09 | Terves, Llc | Galvanically-active in situ formed particles for controlled rate dissolving tools |
| US10865465B2 (en) | 2017-07-27 | 2020-12-15 | Terves, Llc | Degradable metal matrix composite |
| WO2015127174A1 (en) | 2014-02-21 | 2015-08-27 | Terves, Inc. | Fluid activated disintegrating metal system |
| US9910026B2 (en) | 2015-01-21 | 2018-03-06 | Baker Hughes, A Ge Company, Llc | High temperature tracers for downhole detection of produced water |
| US10378303B2 (en) | 2015-03-05 | 2019-08-13 | Baker Hughes, A Ge Company, Llc | Downhole tool and method of forming the same |
| US10221637B2 (en) | 2015-08-11 | 2019-03-05 | Baker Hughes, A Ge Company, Llc | Methods of manufacturing dissolvable tools via liquid-solid state molding |
| US10016810B2 (en) | 2015-12-14 | 2018-07-10 | Baker Hughes, A Ge Company, Llc | Methods of manufacturing degradable tools using a galvanic carrier and tools manufactured thereof |
| TWI755418B (zh) | 2016-08-12 | 2022-02-21 | 美商亞瑟尼克斯公司 | 聯芳組成物和調控激酶級聯之方法 |
| CN108454109B (zh) * | 2018-02-05 | 2023-07-07 | 华北理工大学 | 3d打印机断料提示装置 |
| WO2019240568A1 (es) | 2018-06-14 | 2019-12-19 | Centro De Investigación En Química Aplicada | Método de obtención de partículas porosas mediante un proceso híbrido de pulverización por secado-enfriamiento |
| EP3883546A1 (en) | 2018-11-21 | 2021-09-29 | Rosemont Pharmaceuticals Ltd | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
| EP4171518B1 (en) | 2020-06-26 | 2024-12-11 | Aprecia Pharmaceuticals LLC | Rapidly-orodispersible tablets having an interior cavity |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2508462A (en) * | 1945-03-17 | 1950-05-23 | Union Carbide & Carbon Corp | Method and apparatus for the manufacture of synthetic staple fibers |
| US2826169A (en) * | 1954-01-21 | 1958-03-11 | Veen Harry H Le | Reflective heat insulating coating for animals |
| US2918404A (en) * | 1956-07-30 | 1959-12-22 | Ortho Pharma Corp | Solid compressed amino acid spermicidal vehicle |
| US3067743A (en) * | 1958-11-12 | 1962-12-11 | Alginate Ind Ltd | Alginic compounds |
| US3131428A (en) * | 1958-12-19 | 1964-05-05 | Celanese Corp | Spinneret and spinning method |
| US3036532A (en) * | 1960-06-28 | 1962-05-29 | Bowe John | Cotton candy machine with product of alternating colors |
| US3019745A (en) * | 1960-10-03 | 1962-02-06 | Bois Albert Du | Sugar spinning machine |
| US3070045A (en) * | 1961-04-24 | 1962-12-25 | Bowe John | Machine for spinning sugar |
| NL279172A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1961-06-02 | |||
| US3073262A (en) * | 1961-08-16 | 1963-01-15 | Bowe John | Spinner head for candy cotton machine |
| NL287733A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1962-01-15 | |||
| US3095258A (en) * | 1962-06-22 | 1963-06-25 | Du Pont | Melt spinning process for producing hollow-core filament |
| US3308221A (en) * | 1963-05-14 | 1967-03-07 | Allied Chem | Melt spinning of modified cross section yarn |
| US3595675A (en) * | 1966-11-21 | 1971-07-27 | Gen Mills Inc | Gelatin composition |
| US3615671A (en) * | 1968-04-19 | 1971-10-26 | Gen Foods Corp | Dry food products in spun filaments and method of making same |
| US3723134A (en) * | 1968-05-17 | 1973-03-27 | Gen Mills Inc | Process for making candy floss |
| US3557717A (en) * | 1968-05-17 | 1971-01-26 | Gen Mills Inc | Process for making candy floss |
| US3762846A (en) * | 1968-05-17 | 1973-10-02 | Gen Mills Inc | Process and apparatus for making candy floss |
| US3625214A (en) * | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
| US3951821A (en) * | 1972-07-14 | 1976-04-20 | The Dow Chemical Company | Disintegrating agent for tablets |
| US3875300A (en) * | 1972-12-18 | 1975-04-01 | Ortho Pharma Corp | Composition for sustained release of a medicament and method of using same |
| US3930043A (en) * | 1973-07-19 | 1975-12-30 | Tec Pak Corp | Method for making cotton candy |
| US3856443A (en) * | 1973-08-06 | 1974-12-24 | Gen Properties Anstalt | Apparatus for producing candyfloss |
| US3925525A (en) * | 1973-08-10 | 1975-12-09 | Celanese Corp | Spinning method |
| US4004039A (en) * | 1973-12-03 | 1977-01-18 | General Foods Corporation | Sweetening composition and process therefor |
| GB1460614A (en) * | 1974-04-16 | 1977-01-06 | Tate & Lyle Ltd | Production of crystalline sugar |
| US4136145A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| US3967623A (en) * | 1975-06-30 | 1976-07-06 | Johnson & Johnson | Disposable absorbent pad |
| US3992265A (en) * | 1975-12-31 | 1976-11-16 | American Cyanamid Company | Antibiotic susceptibility testing |
| US4090920A (en) * | 1976-02-19 | 1978-05-23 | Fisher Scientific Company | Disposable antibiotic susceptability test package |
| US4153512A (en) * | 1976-04-07 | 1979-05-08 | Fisher Scientific Company | Storage stable antibiotic susceptibility test kit and method of testing |
| GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4293570A (en) * | 1979-04-02 | 1981-10-06 | Chimicasa Gmbh | Process for the preparation of sweetener containing product |
| US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| US4303684A (en) * | 1980-03-17 | 1981-12-01 | General Foods Corporation | Rapidly-soluble sweetener, process for its preparation and beverage mix employing it |
| US4500546A (en) * | 1980-10-31 | 1985-02-19 | International Telephone And Telegraph Corporation | Suspensions containing microfibrillated cellulose |
| US4585797A (en) * | 1981-04-13 | 1986-04-29 | Seton Company | Cosmetic and pharmaceutical sheet material containing polypeptides |
| US4376743A (en) * | 1981-06-12 | 1983-03-15 | Fiber Industries, Inc. | Melt spinning process |
| JPS5966841A (ja) * | 1982-10-05 | 1984-04-16 | Meiji Seika Kaisha Ltd | 複合繊維状チユ−インガムの製造方法 |
| GB2137470B (en) * | 1983-04-08 | 1986-11-26 | Meiji Seika Kaisha | Fleecy confectionery producing machine |
| WO1985003414A1 (en) * | 1984-01-31 | 1985-08-15 | Scm Corporation | Encapsulation matrix composition and encapsulate containing same |
| IE56300B1 (en) * | 1984-03-19 | 1991-06-05 | Gen Foods Corp | Method for fixing volatile flavorants in extruded vitreous substrates |
| DE3430809A1 (de) * | 1984-08-22 | 1986-03-06 | Merck Patent Gmbh, 6100 Darmstadt | Sucralfat-suspension |
| US4619833A (en) * | 1984-12-13 | 1986-10-28 | General Foods Inc. | Process for producing a rapidly water-soluble, free-flowing, sugar-free dry beverage mix |
| US4692371A (en) * | 1985-07-30 | 1987-09-08 | Kimberly-Clark Corporation | High temperature method of making elastomeric materials and materials obtained thereby |
| US4793782A (en) * | 1986-12-17 | 1988-12-27 | Sells-Floto Inc. | Cotton candy machine |
| US4997856A (en) * | 1987-04-20 | 1991-03-05 | Fuisz Pharmaceutical Ltd. | Method of producing compacted dispersable systems |
| US5011532A (en) * | 1988-03-18 | 1991-04-30 | Fuisz Pharmaceutical Ltd. | Dispersed systems and method of manufacture |
| RU2056835C1 (ru) * | 1987-04-20 | 1996-03-27 | Фьюиз Фармасьютикал Лтд. | Способ получения растворимого лекарственного средства |
| US5387431A (en) * | 1991-10-25 | 1995-02-07 | Fuisz Technologies Ltd. | Saccharide-based matrix |
| US5028632A (en) * | 1987-04-20 | 1991-07-02 | Fuisz Pharmaceutical Ltd. | Taste masked medicated pharmaceutical |
| US4873085A (en) * | 1987-04-20 | 1989-10-10 | Fuisz Pharmaceutical Ltd. | Spun fibrous cosmetic and method of use |
| US5096492A (en) * | 1987-04-20 | 1992-03-17 | Fuisz Technologies Ltd. | Dispersed systems and method of manufacture |
| US4855326A (en) * | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| US5034421A (en) * | 1988-12-13 | 1991-07-23 | Fuisz Pharmaceutical Ltd. | Moderated spun fibrous system and method of manufacture |
| US4923646A (en) * | 1988-11-08 | 1990-05-08 | James River Corporation | Method and apparatus for the manufacture of fibrids |
| US4978537A (en) * | 1989-04-19 | 1990-12-18 | Wm. Wrigley Jr. Company | Gradual release structures for chewing gum |
| NZ235372A (en) * | 1989-10-10 | 1992-05-26 | Wrigley W M Jun Co | Slow release delivery system made by fibre melt spinning techniques producing a fibre about 1mm diameter, exterior is substantially wall material and core mostly active agent dispersed through the fibre material which is porous overall |
| DE4011883A1 (de) * | 1990-04-12 | 1991-10-17 | Bayer Ag | Verfahren zur herstellung von feinstfaservliesen aus thermoplastischen polymeren |
| JPH07501259A (ja) * | 1990-06-01 | 1995-02-09 | リサーチ コーポレイション テクノロジーズ，インコーポレイテッド | 自己乳化型ガラス |
| ZA908406B (en) * | 1990-10-19 | 1991-08-28 | Fuisz Pharmaceutical Ltd | Taste masked medicated floss |
| DE4040242A1 (de) * | 1990-12-15 | 1992-06-17 | Peter Roger Dipl Ing Nyssen | Verfahren und vorrichtung zur herstellung von feinstfasern aus thermoplastischen polymeren |
| FI933044L (fi) * | 1991-11-04 | 1993-09-02 | Fuisz Technologies Ltd | Vattenloesligt system foer avgivning av hydrofoba vaetskor |
| PL170554B1 (pl) * | 1991-12-17 | 1996-12-31 | Fuisz Technologies Ltd | Sposób wytwarzania kompozycji przeciwwrzodowej PL PL PL |
-
1992
- 1992-10-23 US US07/965,804 patent/US5380473A/en not_active Expired - Fee Related
-
1993
- 1993-10-20 CA CA002108832A patent/CA2108832A1/en not_active Abandoned
- 1993-10-21 AU AU49170/93A patent/AU670625B2/en not_active Ceased
- 1993-10-21 DK DK93650034.7T patent/DK0601965T3/da active
- 1993-10-21 DE DE69313418T patent/DE69313418T2/de not_active Expired - Fee Related
- 1993-10-21 EP EP93650034A patent/EP0601965B1/en not_active Expired - Lifetime
- 1993-10-22 PL PL93300831A patent/PL178069B1/pl unknown
- 1993-10-22 JP JP5264993A patent/JPH07308564A/ja active Pending
- 1993-10-23 KR KR1019930022262A patent/KR940008586A/ko not_active Abandoned
- 1993-10-25 MX MX9306622A patent/MX9306622A/es not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112109231A (zh) * | 2020-08-26 | 2020-12-22 | 常宇 | 一种聚丙烯的生产方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0601965B1 (en) | 1997-08-27 |
| MX9306622A (es) | 1994-04-29 |
| DK0601965T3 (da) | 1997-09-29 |
| PL300831A1 (en) | 1994-05-16 |
| US5380473A (en) | 1995-01-10 |
| CA2108832A1 (en) | 1994-04-24 |
| PL178069B1 (pl) | 2000-02-29 |
| DE69313418T2 (de) | 1998-03-26 |
| AU4917093A (en) | 1994-05-05 |
| AU670625B2 (en) | 1996-07-25 |
| DE69313418D1 (de) | 1997-10-02 |
| EP0601965A2 (en) | 1994-06-15 |
| KR940008586A (ko) | 1994-05-16 |
| EP0601965A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1994-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH07308564A (ja) | シヤフォームマトリックスの製造方法及び装置 | |
| US5601076A (en) | Spheroidal crystal sugar and method of making | |
| EP0766514B1 (en) | Flash flow formed solloid delivery systems | |
| CA2448032C (en) | Process and apparatus for producing miniature gum ball centers using an underwater pelletizer | |
| US6174466B1 (en) | Methods for making seamless capsules | |
| RU2185072C2 (ru) | Способ получения стекловидного расплава, стекловидный расплав и содержащие его таблетка и твердая карамель | |
| EP0656426A2 (en) | New Method of making crystalline sugar and products resulting therefrom | |
| JP5373913B2 (ja) | 菓子およびそのような菓子を製造する方法 | |
| WO1995034687A1 (en) | Process for recrystallizing sugar and product thereof | |
| HK1005307A1 (en) | Process for preparing delayed-action medicinal compositions | |
| AU2002305638A1 (en) | Process and apparatus for producing miniature gum ball centers using an underwater pelletizer | |
| CA2426018C (en) | Methods and apparatus for making seamless capsules | |
| US5474792A (en) | Gasified coffee product and process | |
| EP1123009B1 (en) | Process and apparatus for producing shearform matrix material | |
| EP1137813B1 (en) | Method of drying a lactulose solution | |
| WO1999061145A1 (en) | Method and apparatus for forming an encapsulated product matrix | |
| AU723473B2 (en) | New spheroidal crystal sugar and method of making | |
| CA2115808A1 (en) | Polydextrose product and process | |
| MXPA99007850A (en) | Process for producing hard caramels and tablets |